Sleep

What Untreated Sleep Apnea Does to Your Body

Save

Sleep apnea is not just loud snoring. Left untreated, the nightly pattern of airway collapse and oxygen dips puts measurable strain on the heart, the blood vessels, metabolism, and daytime functioning — and much of that harm compounds silently for years before anyone connects it to sleep. Here is what the evidence actually shows, stated without the fear-selling.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How many people have this and never know?

Sleep apnea is far more common than its diagnosis rate suggests, and that gap is the heart of the problem. A widely cited modeling analysis estimated that close to one billion adults aged 30 to 69 worldwide have obstructive sleep apnea, with hundreds of millions in the moderate-to-severe range — and that the large majority have never been diagnosed 1. The harm this page describes accrues in exactly that undiagnosed group, night after night, with no one treating it.

That is why what happens if you don't treat it is not a hypothetical. For most people the honest answer is that they have been living the early version of it already — the unrefreshing sleep, the mid-afternoon crash, the blood pressure that will not settle — and simply attributing it to age, stress, or a heavy workload. Close to a billion adults worldwide are estimated to have obstructive sleep apnea, and most are undiagnosed 1.

What untreated apnea does to the heart and blood vessels

The clearest physical toll of untreated apnea lands on the cardiovascular system. Each time the airway collapses, oxygen falls and the body jolts the nervous system awake enough to reopen it; repeated hundreds of times a night, that pattern drives up blood pressure, strains the heart, and stresses the vessel walls. One observational cohort followed men for years and found that those with untreated severe apnea suffered fatal cardiovascular events at roughly 2.9 times the rate of healthy men, and non-fatal ones at about 3.2 times, whereas the men who used CPAP sat close to the healthy baseline 2.

Untreated apnea is also one of the best-recognized drivers of high blood pressure that resists medication. Blood pressure normally dips during healthy sleep; in untreated apnea the constant arousals blunt that overnight dip, so the heart and vessels never get their nightly rest and the strain leaks into the daytime numbers. And the connection between sleep apnea and atrial fibrillation is established enough that many cardiologists look for apnea when an irregular heart rhythm keeps returning after treatment. None of this means apnea guarantees heart disease. It means the airway problem and the cardiovascular problem are physically linked, and treating the first is part of managing the second — which is why a cardiology work-up increasingly includes a question about how you sleep.

The mortality question, answered honestly

The mortality data deserve a careful, non-alarmist reading. A separate cohort tracked participants in Wisconsin across eighteen years and recorded higher death rates — overall and from cardiovascular causes — among those with severe sleep-disordered breathing, with the steepest excess in the people whose apnea went untreated 3. That is a real and sobering signal, and it is specifically about severe, untreated disease measured over long spans of time.

It is also observational, which sets an honest ceiling on what it proves. A cohort study can show that severe untreated apnea travels with higher mortality; it cannot, on its own, prove that treatment erases that risk. The reasonable takeaway is not panic but attention: severe apnea is worth finding and treating, and the longer it goes untreated, the more the associated risks have time to accumulate. Read this as a reason to get tested, not a reason to lie awake counting your breaths.

What treatment reliably reverses, and what it may not

Here is the honest ledger on treatment, because it changes how you read everything above. The benefit that randomized trials prove most cleanly is symptomatic. The SAVE trial randomized thousands of people who had moderate-to-severe apnea alongside existing heart disease; adding CPAP on top of usual care left the count of cardiovascular events essentially unchanged, yet it eased daytime sleepiness and snoring and lifted mood and quality-of-life scores 4. So the strongest proof is that treatment makes people feel and function better; the cardiovascular case rests more on observational data than on a clean randomized trial.

Why say this on a dangers page? Because precision is what separates useful information from fear-selling. Treating apnea is well worth doing — the daytime gains alone are substantial, and the risk associations are consistent and pointed in one direction — but the promise is not a guaranteed rewind of every cardiovascular risk you have already built up. Knowing the difference lets you weigh treatment realistically, out of self-interest rather than dread, which is a far more durable reason to stick with it.

The daytime toll: alertness, mood, and memory

The daytime toll is the part people most underestimate, and it is the part treatment most reliably fixes. Chronic apnea fragments sleep so thoroughly that the days blur together: heavy sleepiness, a shorter fuse, low mood, slower thinking, and trouble holding attention or forming new memories. These are exactly the outcomes the SAVE trial watched improve with treatment — daytime sleepiness, mood, and quality of life 4. The sleepiness is not only a comfort issue; drifting off at the wheel is one of the genuine dangers of untreated apnea, and it is a safety and legal matter, not a character flaw.

Brain fog, morning headaches, and irritability get blamed on stress or aging when the real driver is an airway that keeps closing at night and an oxygen level that keeps dipping. Over months and years the sleep debt compounds: reaction times slow, patience thins, and work that used to feel easy takes visible effort. The morning headache in particular is a classic clue, thought to come from the overnight rise in carbon dioxide, and it often eases once breathing is steadied through the night. The daytime symptoms — sleepiness, fog, low mood — are usually among the first things to lift once effective treatment starts.

The metabolic connection: blood sugar and weight

Untreated apnea and metabolic trouble reinforce each other. The nightly stress response and fragmented sleep are linked with insulin resistance and harder-to-control blood sugar, which is part of why obstructive sleep apnea and type 2 diabetes so often appear together, each one making the other worse. Weight is frequently the shared thread: excess weight raises apnea risk, and short, broken sleep nudges appetite and metabolism in the wrong direction, tightening the loop. For someone already living with type 2 diabetes, untreated apnea can make blood sugar harder to control and can blunt the benefit of otherwise careful management, which is why sleep is increasingly treated as part of a diabetes review rather than an afterthought.

This is also where some of the newer options enter the picture. Because weight is a genuinely modifiable driver of apnea, the arrival of potent weight-loss medications has changed the conversation, and the specific evidence on GLP-1s for sleep apnea is covered on its own page. The practical point for this one is that untreated apnea is rarely just a breathing problem in isolation; it sits inside a web of blood pressure, blood sugar, and weight that all move together, and leaving the apnea untreated keeps a finger on that whole scale.

Why apnea so often goes undiagnosed

Apnea goes undiagnosed so often partly because the stereotype is wrong. The classic picture — an older, heavyset man who snores like a chainsaw — is real but incomplete, and it causes sleep apnea in women to be missed for years, because women more often describe fatigue, insomnia, or low mood than thunderous snoring. Slim people get it too, especially with certain jaw shapes and narrow airways. So the absence of the stereotype is not the reassurance it feels like.

The risk factors worth knowing are concrete: loud habitual snoring, witnessed pauses in breathing, heavy daytime sleepiness, high blood pressure, a larger neck circumference, and older age, among others. When several sleep apnea risk factors line up, the odds of undiagnosed disease climb steeply, and that is the cue to get evaluated rather than to keep explaining the symptoms away one at a time.

Getting evaluated before the harm compounds

Getting evaluated is the entire point of a page like this, and the path is more straightforward than most people expect. It usually starts with a validated screening questionnaire — STOP-Bang is the common one — which combines eight factors (snoring, tiredness, observed pauses, blood pressure, body size, age, neck size, and sex) to sort who is likely to have moderate-to-severe apnea. A meta-analysis found STOP-Bang is highly sensitive for detecting moderate-to-severe disease, with sensitivity climbing at higher scores 5. A positive screen leads to an actual sleep test, at home or in a lab — never to a diagnosis on its own. And a confirmed diagnosis opens a real menu of treatments, from CPAP and oral appliances to weight-directed approaches and, in selected cases, surgery for sleep apnea options — meaning a positive result is the start of a solvable problem, not a dead end.

One nuance keeps this honest: national guidance does not recommend blanket screening of adults who have no symptoms, because the evidence to justify testing the whole population is not there 6. That is not a reason for a symptomatic or high-risk person to wait — it is the opposite. If you have the symptoms or the risk factors, that is precisely the situation testing exists for, and the sooner the test happens, the less time an invisible problem has to compound.

The through-line, without the fear

The through-line is simpler than the list of organs suggests. Untreated obstructive sleep apnea is a chronic, whole-body stressor: it strains the heart and vessels, tangles with blood pressure and blood sugar, and steadily taxes mood, alertness, and safety — and the strongest evidence says treatment reliably restores the daytime half of that ledger. The risks are real without being a sentence, and nearly all of them are more manageable the sooner the apnea is found.

So the useful response to what happens if I don't treat it is not fear; it is a test. If the symptoms or risk factors fit, an evaluation turns an invisible, compounding problem into a treatable one — and for a condition this common and this quiet, that is the whole game.

Common questions

Untreated obstructive sleep apnea strains the heart and blood vessels, raises blood pressure, tangles with blood sugar and weight, and drags down daytime alertness, mood, and concentration. Observational studies also link severe, untreated apnea with higher cardiovascular risk and mortality. Much of the daytime harm is the most reliably reversible part once effective treatment begins.

There is no fixed clock. The nightly strain accumulates gradually, so many people feel the daytime effects — fatigue, fog, low mood — for years before any diagnosis, while the cardiovascular and metabolic associations build over the same long span. The practical answer is that the sooner it is found and treated, the less time it has to compound.

Severe, untreated apnea is associated with higher all-cause and cardiovascular mortality in long observational studies, and its daytime sleepiness is a real driving hazard. That association is strongest for severe disease left untreated over years. It is not a fixed sentence, and it is largely modifiable — which is exactly why finding and treating it matters so much.

Partly, and honestly the daytime half is the surest. Trials show treatment reliably improves sleepiness, mood, and quality of life. Its effect on already-established cardiovascular events is less certain, because the strongest evidence there is observational rather than from a clean randomized trial. Treatment is well worth doing; it is just not a guaranteed rewind of every risk.

The cues are concrete: loud habitual snoring, witnessed breathing pauses, heavy daytime sleepiness, hard-to-control blood pressure, a larger neck, and older age. A validated screen like STOP-Bang sorts who is likely to have moderate-to-severe apnea, but only an actual sleep test — at home or in a lab — can confirm it. If several risk factors stack up, that is the cue to get evaluated.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Signs untreated sleep apnea needs prompt attention

  • —Falling asleep involuntarily while driving, at work, or mid-conversation — this level of sleepiness is a safety emergency, not just tiredness.
  • —A bed partner witnessing long pauses in breathing followed by gasping, choking, or silence, especially alongside a pounding or irregular heartbeat.
  • —Morning headaches with breathlessness when lying flat, ankle swelling, or blood pressure that will not come under control on medication.

If you catch yourself nodding off while driving, stop driving and arrange an urgent evaluation before you drive again; call 911 for chest pain, fainting, or a sudden irregular heartbeat.

This article explains the risks of untreated sleep apnea for educational purposes and is not medical advice. Whether you have apnea, how severe it is, and what to do about it depend on a diagnostic evaluation and your own health history, which belong with a qualified clinician.

References

  1. 1.Benjafield AV, Ayas NT, Eastwood PR, et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine. doi:10.1016/S2213-2600(19)30198-5 ✓Modeling estimate that nearly one billion adults aged 30-69 worldwide have obstructive sleep apnea, hundreds of millions moderate-to-severe, with most cases undiagnosed.
  2. 2.Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet. doi:10.1016/S0140-6736(05)71141-7 ✓Observational cohort: untreated severe OSA was associated with roughly 2.9-fold fatal and 3.2-fold non-fatal cardiovascular event rates versus healthy controls, while CPAP-treated risk was similar to controls.
  3. 3.Young T, Finn L, Peppard PE, et al. (2008). Sleep Disordered Breathing and Mortality: Eighteen-Year Follow-up of the Wisconsin Sleep Cohort. Sleep. doi:10.1093/sleep/31.8.1071 ✓Eighteen-year cohort follow-up: severe sleep-disordered breathing was associated with higher all-cause and cardiovascular mortality, an association strongest in those not treated with CPAP.
  4. 4.McEvoy RD, Antic NA, Heeley E, et al. (SAVE Investigators) (2016). CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. New England Journal of Medicine. doi:10.1056/NEJMoa1606599 ✓In the SAVE randomized trial, CPAP added to usual care did not reduce cardiovascular events but reduced daytime sleepiness and snoring and improved mood and quality of life.
  5. 5.Nagappa M, Liao P, Wong J, et al. (2015). Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis. PLOS ONE. doi:10.1371/journal.pone.0143697 ✓Meta-analysis: STOP-Bang has high sensitivity for detecting moderate-to-severe OSA across populations, with sensitivity increasing at higher score thresholds.
  6. 6.US Preventive Services Task Force (Mangione CM, et al.) (2022). Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. USPSTF / JAMA. link ✓USPSTF 'I' statement: current evidence is insufficient to assess the balance of benefits and harms of screening asymptomatic adults for OSA (does not apply to testing symptomatic or at-risk patients).

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library